Search results
Results from the WOW.Com Content Network
Noland Arbaugh (born 1993 or 1994) is an American quadriplegic known for being the first human recipient of Neuralink's brain-computer interface (BCI) implant. [1] He gained attention for his use of the device to regain digital autonomy after a spinal cord injury left him paralyzed.
Neuralink Corp. [4] is an American neurotechnology company that has developed, as of 2024, implantable brain–computer interfaces (BCIs). It was founded by Elon Musk and a team of eight scientists and engineers.
Elon Reeve Musk (/ ˈ iː l ɒ n m ʌ s k /; born June 28, 1971) is a businessman known for his key roles in the space company SpaceX and the automotive company Tesla, Inc. He is also known for his ownership of X Corp. (the company that operates the social media platform X, formerly Twitter), and his role in the founding of the Boring Company, xAI, Neuralink, and OpenAI.
Blindsight is being developed to enable individuals with total visual impairment due to damage to the optic nerve but with intact visual cortex to see, this is made possible by bypassing the optic nerve and directly stimulating the visual cortex to create a visual perception.
He is the chief executive officer of neurotechnology company Neuralink and the wealth manager of billionaire entrepreneur Elon Musk since 2016. As Musk's adviser, right-hand man, and fixer, Birchall holds executive or administrative positions in other endeavors of his including the Boring Company, Musk Foundation, xAI, and managing his family ...
Rapoport was previously on the eight-member founding team at Elon Musk’s brain–computer interface company, Neuralink. Rapoport left Neuralink in 2018. [1] Rapoport, along with Michael Mager, an investor and business builder, and a team of experts in areas such as neuroscience, microfabrication and software launched Precision Neuroscience in ...
Within two weeks, a vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. [9] On 30 December 2020, the Oxford–AstraZeneca COVID-19 vaccine she co-developed with the Oxford Vaccine Group was approved for use in the UK. [10] More than 3 billion doses of the vaccine were supplied to countries ...
Özlem Türeci (Turkish pronunciation: [ˈœzlem ˈtyredʒi]; born 6 March 1967) is a German physician, scientist and entrepreneur. In 2008, she co-founded the biotechnology company BioNTech, which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19. [2]